[ZLTQ] ZELTIQ Aesthetics, Inc.
Overview
Type of security: Stock
Sector: Health Care
Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Strongest Trends Summary For ZLTQ
ZLTQ is in the long-term up 743% in 9 years.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: ZELTIQ Aesthetics, Inc., a medical technology company, is engaged in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. The company sells its products through a network of distributors, as well as a direct sales force to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was founded in 2005 and is headquartered in Pleasanton, California.
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | 9.56% | Sales Growth - Q/Q | 1.55% | P/E | ||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | 6.52% | ROE | 9.77% | ROI | ||
| Current Ratio | 2.71 | Quick Ratio | 2.18 | Long Term Debt/Equity | Debt Ratio | 0.48 | |
| Gross Margin | 71.59% | Operating Margin | 3.92% | Net Profit Margin | 3.45% | Dividend Payout Ratio | |
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | -2.83 M | Cash From Investing Activities | 4.1 M | Cash From Operating Activities | 7.23 M | Gross Profit | 46.31 M |
| Net Profit | 1.18 M | Operating Profit | 1.65 M | Total Assets | 118.71 M | Total Current Assets | 104.02 M |
| Total Current Liabilities | 43.47 M | Total Debt | 320 K | Total Liabilities | 44.46 M | Total Revenue | 64.43 M |
Technical Data
| High 52 week | 37.53 | Low 52 week | 19.26 | Last close | 29.34 | Last change | 2.02% |
| RSI | 61.38 | Average true range | 1.07 | Beta | 1.4 | Volume | 319.07 K |
| Simple moving average 20 days | 6.46% | Simple moving average 50 days | 6.15% | Simple moving average 200 days | 4.82% |
Performance Data
| Performance Week | 7.35% | Performance Month | -0.54% | Performance Quart | 2.66% | Performance Half | 8.75% |
| Performance Year | 6.77% | Performance Year-to-date | 2.84% | Volatility daily | 2.07% | Volatility weekly | 4.62% |
| Volatility monthly | 9.47% | Volatility yearly | 32.79% | Relative Volume | 194.97% | Average Volume | 689.28 K |
| New High | 16.2% | New Low |
News
2017-04-28 11:06:03 | IDEXX Laboratories IDXX Beats Q1 Earnings, Raises View
2017-04-28 10:55:02 | ResMed RMD Beats Q3 Earnings, Misses Sales Estimates
2017-04-28 09:37:01 | Abaxis ABAX Beats Q4 Earnings Estimates, Revenues In Line
2017-04-27 16:54:08 | Mead Johnson MJN Lags Q1 Earnings, Awaits Merger Closure
2017-04-27 15:44:07 | Zimmer Biomet ZBH Beats on Q1 Earnings, Lowers Guidance
2017-04-27 08:23:12 | Integra LifeSciences IART Misses Q1 Earnings, Retains View
2017-04-26 10:46:02 | Thermo Fisher TMO Tops Q1 Earnings, Sales, Raises Guidance
2017-04-26 10:18:02 | Illumina ILMN Posts In-line Earnings in Q1, Margins Down
2017-04-26 09:48:01 | Edwards Lifesciences EW Tops Q1 Earnings, Updates '17 View
2017-04-26 08:46:12 | NuVasive NUVA Beats on Q1 Earnings, Retains 2017 View
2017-04-25 17:58:00 | PBF Energy Set to Join S&P MidCap 400; Apollo Commercial Real Estate Finance and Waddell & Reed Financial to Join S&P SmallCap 600
2017-04-25 10:27:02 | LabCorp LH Tops Q1 Earnings, Misses on Sales, Tweaks View
2017-04-20 09:30:01 | Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne
2017-04-20 08:35:12 | Rockwell Medical RMTI Catches Eye: Stock Moves Up 12.1%
2017-04-19 07:42:11 | Create an Efficient Portfolio with 5 Top Stocks
2017-04-19 07:41:11 | GNC Holdings GNC Q1 Earnings & Revenues Top, Decline Y/Y
2017-04-13 15:01:07 | Boston Scientific's Emerging Markets Grow Amid Currency Woes
2017-04-13 08:57:12 | Align ALGN Upgraded to Buy on Invisalign System Prospects
2017-04-12 09:36:01 | Haemonetics' Plasma Group Strong, Blood Center Group a Drag
2017-04-11 16:17:08 | ResMed's Study Results for Central Sleep Apnea Hold Promise
2017-04-06 09:47:01 | Medtronic HVAD System Results Positive for Long-Term Therapy
2017-04-06 08:50:12 | IDEXX Laboratories' CAG Revenues Solid, Competition Rife
2017-04-06 08:00:00 | Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction
2017-04-05 11:44:03 | Walgreens Boots WBA Meets Q2 Earnings, Retains EPS View
2017-04-04 10:21:12 | SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against ZELTIQ Aesthetics, Inc.
2017-04-04 09:03:01 | Walgreens, Prime Form Central Specialty & Mail Service Company
2017-04-04 08:12:00 | CoolSculpting® and Debra Messing Partner to Inspire Confidence and Cool Moments
2017-04-03 09:03:01 | NuVasive Receives FDA 510k Clearance in Cervical Spine
2017-04-03 08:46:12 | Amedisys to Buy East Tennessee to Expand in Personal Care
2017-03-31 09:44:01 | Abbott's St Jude Buyout to Boost Business, Risks Remain
2017-03-30 09:47:01 | Genomic Health's GPS Predicts Metastatic Prostate Cancer
2017-03-30 09:13:01 | NuVasive NUVA Gets FDA 510k Clearance for CoRoent System
2017-03-30 08:49:00 | QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics
2017-03-24 12:02:35 | Allergan Hoovers Aesthetics Market; Can Hologic Play?
2017-03-15 16:38:30 | ZELTIQ AESTHETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
2017-03-13 14:48:00 | INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders
2017-03-13 08:03:00 | ZELTIQ AESTHETICS ZLTQ SHAREHOLDER ALERT – Andrews & Springer LLC is Investigating ZELTIQ Aesthetics, Inc. for Potential Breaches of Fiduciary Duty
2017-03-09 12:19:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ZELTIQ Aesthetics, Inc. - ZLTQ
2017-03-07 11:44:52 | ZELTIQ Aesthetics, Inc. :ZLTQ-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
2017-03-03 09:00:00 | ZELTIQ® Showcases CoolAdvantage Petite™ Applicator for the CoolSculpting® System at American Academy of Dermatology Annual Meeting
2017-03-01 17:48:55 | Zeltiq beats Street 4Q forecasts
2017-03-01 16:34:57 | ZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
2017-03-01 16:17:51 | ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results
2017-03-01 08:59:01 | Hit ETFs & Stocks from the Top Sector of February
2017-02-22 07:30:07 | [$$] Gormley's Take: Body Beautification Is Sexy Business
2017-02-21 10:58:00 | Medtronic Earnings Rebound in Third Quarter, Shares Climb
2017-02-17 18:49:00 | SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of ZELTIQ Aesthetics, Inc. -ZLTQ
2017-02-16 15:28:00 | INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZELTIQ Aesthetics, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
2017-02-15 16:36:12 | ZELTIQ AESTHETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa